CareMessage

Back to Portfolio

Model & Strategy

CareMessage helps clinics, hospitals, community programs and government agencies connect with at-risk patients through the use of text and voice messaging. CareMessage’s software enables partner organizations to automate follow-ups and data collection and to provide disease management, giving patients a critically important information channel to address their healthcare needs.

The organization has also developed text messaging-based disease management programs to enable low-income patients to self-manage various common chronic conditions, including type 2 diabetes, hypertension, high cholesterol, childhood obesity, congestive heart failure, emphysema, COPD, asthma, HIV and depression.

At a Glance
Founded: 2012
By: Vineet Singal
Health
Location of work: Domestic, Northeast, West Coast
http://www.caremessage.org
CareMessage
332 Pine Street
Suite 300
San Francisco, CA 94104
Care. Better. Together.
Vineet Singal of CareMessage
Meet Vineet Singal

For Vineet, his childhood obesity meant years of bullying and struggle but ultimately he overcame pre-diabetes and lost over a hundred pounds in the process. This experience inspired him to take a leave of absence from Stanford to volunteer at a free clinic in Galveston, TX, a city ravaged by a Category 4 hurricane and the 2008 economic crisis. His work with the underserved community in Galveston highlighted the crippling long-term effects that chronic diseases have on low-income, uninsured patients and the dearth of existing resources to serve this growing need. Vineet returned to Stanford with a commitment to make a difference and co-founded CareMessage. Upon graduation, Vineet decided to turn down a full scholarship to a top-tier medical school to continue to pursue his passion as CareMessage CEO.

Vineet was honored as a Forbes 30 under 30 social entrepreneur, a 2013 Echoing Green Fellow, and an alumnus of Y Combinator.

IMPACT

In Phase I of their evaluation, CareMessage demonstrated a 92% retention rate and a 70% engagement rate, amongst primarily low-income patient populations.

Phase II evaluations have shown reduced no-show rates for appointments, improvements in rates of preventive screenings, reductions in Finger Stick Blood Glucose levels for diabetic patients, and improved medication adherence for high cholesterol patients.

CareMessage grew the number of reachable patients on the platform from 500,000 at the beginning of 2016 to more than 1.4 million by the end of 2017 and works with more than 200 customers in 37 states across the US.  

CareMessage News

All News

Learn More